Current role
William K. McVicar
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About William K. McVicar
The proxy statement of Decoy Therapeutics Inc. reports total compensation of $1,160,523 for William K. McVicar in fiscal 2019, including a base salary of $272,956. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Decoy Therapeutics Inc. (DCOY)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2020-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Decoy Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Frederick E. Pierce CEO, Board Member
- Mark J. Rosenblum CFO
- Arnold C. Hanish Board Member
- David J. Arthur Board Member
- Jonathan Lieber Board Member
- Patricia Gauthier Board Member
- Paul Lammers Board Member
- Tess Burleson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Decoy Therapeutics Inc. (DCOY) | Former Chief Executive Officer of Flex Pharma, Inc. | $272,956 | $1,160,523 |
| 2018 | Decoy Therapeutics Inc. (DCOY) | Former Chief Executive Officer of Flex Pharma, Inc. | $490,000 | $1,798,404 |
Recent activity
No call appearances or filed executive changes recorded yet.